• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型5-羟色胺(5HT)摄取抑制剂帕罗西汀(FG 7051)可有效降低猴全血中的5HT水平。

Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051).

作者信息

Petersen E N, Bechgaard E, Sortwell R J, Wetterberg L

出版信息

Eur J Pharmacol. 1978 Nov 1;52(1):115-9. doi: 10.1016/0014-2999(78)90028-6.

DOI:10.1016/0014-2999(78)90028-6
PMID:102515
Abstract

The potent 5-hydroxytryptamine (5HT) uptake inhibitor FG 7051 (paroxetine, INN) was administered to rhesus monkeys in doses of 1.0, 2.5 or 7.5 mg/kg by oral gavage once daily for 13 weeks. Blood samples for analysis of 5HT in whole blood and paroxetine in plasma were taken prior to and after 1, 4 and 13 weeks of treatment. The lowest dose 1 mg/kg caused 30% depletion of 5HT in whole blood with a level of paroxetine in plasma below 2 ng/ml. Doses of 2.5 mg/kg produced an 85% depletion of 5HT and a steady state plasma concentration of about 5 ng paroxetine/ml, while 7.5 mg/kg caused a 93% depletion of 5HT and a steady state plasma concentration of 100--450 ng paroxetine/ml. There was no concentration-dependent 5HT reduction with the highest dose level suggesting that maximal depletion was produced by concentrations below 100 ng/ml. The results showed that paroxetine is a strong depletor of 5HT from whole blood of monkeys conceivably because it inhibits 5HT uptake inhibition. The effect of the drug reached its maximum within 1 week and no tolerance developed during 13 weeks.

摘要

强效5-羟色胺(5HT)摄取抑制剂FG 7051(帕罗西汀,国际非专利药品名称)以1.0、2.5或7.5mg/kg的剂量通过口服灌胃给予恒河猴,每日一次,持续13周。在治疗1、4和13周之前和之后采集血样,用于分析全血中的5HT和血浆中的帕罗西汀。最低剂量1mg/kg导致全血中5HT耗竭30%,血浆中帕罗西汀水平低于2ng/ml。2.5mg/kg的剂量使5HT耗竭85%,血浆中帕罗西汀稳态浓度约为5ng/ml,而7.5mg/kg导致5HT耗竭93%,血浆中帕罗西汀稳态浓度为100 - 450ng/ml。最高剂量水平下不存在浓度依赖性5HT降低,这表明浓度低于100ng/ml时产生了最大耗竭。结果表明,帕罗西汀是猴子全血中5HT的强效耗竭剂,可能是因为它抑制5HT摄取。药物作用在1周内达到最大值,并且在13周内未产生耐受性。

相似文献

1
Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051).一种新型5-羟色胺(5HT)摄取抑制剂帕罗西汀(FG 7051)可有效降低猴全血中的5HT水平。
Eur J Pharmacol. 1978 Nov 1;52(1):115-9. doi: 10.1016/0014-2999(78)90028-6.
2
An early clinical phase II evaluation of paroxetine, a new potent and selective 5HT-uptake inhibitor in patients with depressive illness.对一种新型强效选择性5-羟色胺摄取抑制剂帕罗西汀在抑郁症患者中的早期临床II期评估。
Pharmacopsychiatria. 1982 Nov;15(6):183-6. doi: 10.1055/s-2007-1019535.
3
Paroxetine: pharmacokinetics, tolerance and depletion of blood 5-HT in man.帕罗西汀:人体中的药代动力学、耐受性及血液5-羟色胺耗竭情况
Acta Pharmacol Toxicol (Copenh). 1979 Apr;44(4):289-95. doi: 10.1111/j.1600-0773.1979.tb02332.x.
4
Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine.单胺摄取抑制剂对大鼠血液中细胞外和血小板5-羟色胺的影响:氯米帕明和氟西汀的不同作用
Br J Pharmacol. 1992 Apr;105(4):941-6. doi: 10.1111/j.1476-5381.1992.tb09082.x.
5
Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.高剂量芬氟拉明治疗对大鼠脑内单胺摄取位点的影响:采用定量放射自显影术进行评估
Synapse. 1990;6(1):33-44. doi: 10.1002/syn.890060105.
6
Verapamil inhibition of 5-hydroxytryptamine (5HT) uptake in rat platelets.维拉帕米对大鼠血小板摄取5-羟色胺(5HT)的抑制作用。
Eur J Pharmacol. 1987 Jun 4;137(2-3):273-5. doi: 10.1016/0014-2999(87)90235-4.
7
Inhibition and dissociation of [3H]-paroxetine binding to human platelets.[3H] -帕罗西汀与人血小板结合的抑制和解离
Neuropsychobiology. 1989;22(3):135-40. doi: 10.1159/000118607.
8
Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property.
Eur J Pharmacol. 1977 Jun 1;43(3):209-15. doi: 10.1016/0014-2999(77)90019-x.
9
Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.长期接受非莫西汀、帕罗西汀和氯米帕明治疗的大鼠的中枢和外周5-羟色胺摄取情况。
Psychopharmacology (Berl). 1980;68(3):229-33. doi: 10.1007/BF00428108.
10
Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets.新型5-羟色胺能受体拮抗剂酮色林对大鼠和人血小板中5-羟色胺诱导的形态变化及5-羟色胺摄取的比较作用。
Biochem Pharmacol. 1982 Sep 15;31(18):3000-2. doi: 10.1016/0006-2952(82)90277-5.

引用本文的文献

1
Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的代谢与药代动力学
Cell Mol Neurobiol. 1999 Aug;19(4):443-66. doi: 10.1023/a:1006934807375.
2
Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.选择性5-羟色胺再摄取抑制剂的药代动力学-药效学关系
Clin Pharmacokinet. 1996 Dec;31(6):444-69. doi: 10.2165/00003088-199631060-00004.
3
Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
长期接受非莫西汀、帕罗西汀和氯米帕明治疗的大鼠的中枢和外周5-羟色胺摄取情况。
Psychopharmacology (Berl). 1980;68(3):229-33. doi: 10.1007/BF00428108.
4
EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers.
Psychopharmacology (Berl). 1984;83(4):327-9. doi: 10.1007/BF00428539.
5
A water lick conflict paradigm using drug experienced rats.
Psychopharmacology (Berl). 1981;75(3):236-9. doi: 10.1007/BF00432430.
6
Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium.在接受单胺摄取抑制剂、5-羟色胺拮抗剂和锂治疗的小鼠中,尼亚酰胺诱导的运动亢进。
Psychopharmacology (Berl). 1989;98(2):257-61. doi: 10.1007/BF00444701.
7
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.帕罗西汀。对其药效学和药代动力学特性以及在抑郁症治疗中的潜力的综述。
Drugs. 1991 Feb;41(2):225-53. doi: 10.2165/00003495-199141020-00007.